SEC Form 4 reporting owner

Xu Zhenyu

Xu Zhenyu has filed 27 Form 4 transactions reported between March 19, 2026 and September 14, 2026, as Chief Scientific Officer of SOPHiA GENETICS SA.

Name as filed: Xu Zhenyu

Open-market buys, 24 mo
None
reported
Open-market sales, 24 mo
$655K
23 lines
Companies
1
with Form 4 filings
Latest transaction
Sep 14, 2026
transaction date

Roles and reported holdings

  • SOPHSOPHiA GENETICS SA
    Mar 19, 2026 – Sep 14, 2026

    Chief Scientific Officer

    Held directly552,887 sh as of Sep 14, 2026 · Form 4

    24 months: $655K sold

Transaction history

All 27 reported transactions, newest first. Every row links to the Form 4 on SEC EDGAR.

DateCompanyTypeSharesValueFiling
Sep 14, 2026SOPHChief Scientific OfficerOpen-market saleCode S · direct4,000$32K@ $7.88Form 4
Aug 27, 2026SOPHChief Scientific OfficerOpen-market saleCode S · direct10,000$89K@ $8.91Form 4
Aug 21, 2026SOPHChief Scientific OfficerOpen-market saleCode S · direct5,408$45K@ $8.40Form 4
Aug 20, 2026SOPHChief Scientific OfficerOpen-market saleCode S · direct4,592$39K@ $8.41Form 4
Aug 19, 2026SOPHChief Scientific OfficerOpen-market saleCode S · direct10,000$79K@ $7.94Form 4
Aug 13, 2026SOPHChief Scientific OfficerOpen-market saleCode S · direct4,000$30K@ $7.52Form 4
Aug 7, 2026SOPHChief Scientific OfficerOpen-market saleCode S · direct10,000$75K@ $7.48Form 4
Aug 7, 2026SOPHChief Scientific OfficerOption exerciseCode M · direct7,000$23K@ $3.28Form 4
Aug 5, 2026SOPHChief Scientific OfficerOption exerciseCode M · direct3,000$10K@ $3.28Form 4
Aug 4, 2026SOPHChief Scientific OfficerOpen-market saleCode S · direct10,000$69K@ $6.92Form 4
Jul 13, 2026SOPHChief Scientific OfficerOpen-market saleCode S · direct4,000$23K@ $5.70Form 4
Jul 6, 2026SOPHChief Scientific OfficerOpen-market saleCode S · direct7,393$38K@ $5.17Form 4
Jun 15, 2026SOPHChief Scientific OfficerOpen-market saleCode S · direct4,000$20K@ $5.01Form 4
May 19, 2026SOPHChief Scientific OfficerOpen-market saleCode S · direct608$3K@ $4.60Form 4
May 13, 2026SOPHChief Scientific OfficerOpen-market saleCode S · direct4,000$18K@ $4.54Form 4
Apr 20, 2026SOPHChief Scientific OfficerOpen-market saleCode S · direct608$3K@ $5.21Form 4
Apr 14, 2026SOPHChief Scientific OfficerOpen-market saleCode S · direct600$3K@ $4.97Form 4
Apr 13, 2026SOPHChief Scientific OfficerOpen-market saleCode S · direct3,400$16K@ $4.76Form 4
Apr 13, 2026SOPHChief Scientific OfficerOpen-market saleCode S · direct1,014$5K@ $4.76Form 4
Apr 10, 2026SOPHChief Scientific OfficerOpen-market saleCode S · direct3,706$17K@ $4.68Form 4
Apr 9, 2026SOPHChief Scientific OfficerOpen-market saleCode S · direct1,936$9K@ $4.74Form 4
Apr 8, 2026SOPHChief Scientific OfficerOpen-market saleCode S · direct2,800$14K@ $4.84Form 4
Apr 7, 2026SOPHChief Scientific OfficerOpen-market saleCode S · direct2,400$12K@ $4.87Form 4
Apr 6, 2026SOPHChief Scientific OfficerOpen-market saleCode S · direct2,700$13K@ $4.85Form 4
Apr 2, 2026SOPHChief Scientific OfficerGrant or awardCode A · direct164,671—Form 4
Apr 2, 2026SOPHChief Scientific OfficerGrant or awardCode A · direct112,936—Form 4
Mar 19, 2026SOPHChief Scientific OfficerOpen-market saleCode S · direct608$3K@ $4.78Form 4

How this page is built

Every row comes from a Form 4 filed with the SEC, which officers, directors and holders of more than 10% of a company’s stock must file within two business days of a trade. Transactions are grouped by the reporting owner’s name as filed (spacing, capitals and punctuation ignored); two different people filing under an identical name would appear together, and one person filing under two spellings appears on two pages.

Open-market totals count code P purchases and code S sales over the last 24 months. The same trade reported on more than one filing is counted once; when another owner (for example a fund and its general partner) reports the identical trade, they are listed beside it. Holdings are the shares owned after the latest purchase, sale, gift or tax-withholding line, shown separately for direct and indirect ownership; an indirect figure is one holding line, not a total across every trust or entity.

This page describes what was filed with the SEC; it is not investment advice or a recommendation to buy or sell any security.